Patent: 5,359,032
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Summary for Patent: 5,359,032
| Title: | Interkeukin-1 inhibitor |
| Abstract: | This invention relates to interleukin inhibitors (IL-1 INHs) that selectively inhibit interleukin 1 activity. The invention also relates to processes for purifying such IL-1 INHs from urine and for producing such IL-1 INHs by hosts transformed with recombinant DNA molecules comprising DNA sequences encoding the inhibitors, and to methods of treatment and compositions characterized by such IL-1 INHs. These methods and agents are useful in immunosuppressive and anti-inflammatory applications and therapies. |
| Inventor(s): | Dayer; Jean M. (Geneva, CH), Seckinger; Philippe L. (Carouge, CH), Mazzei; Gonzalo J. (Geneva, CH), Shaw; Alan R. (Geneva, CH) |
| Assignee: | Biogen Inc. (Cambridge, MA) |
| Application Number: | 07/985,506 |
| Patent Claims: | see list of patent claims |
Details for Patent 5,359,032
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Smith & Nephew, Inc. | SANTYL | collagenase | Ointment | 101995 | 06/04/1965 | See Plans and Pricing | 2011-10-25 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
